Published online Jun 28, 2023. doi: 10.4329/wjr.v15.i6.191
Peer-review started: March 13, 2023
First decision: May 9, 2023
Revised: May 17, 2023
Accepted: June 16, 2023
Article in press: June 16, 2023
Published online: June 28, 2023
Processing time: 106 Days and 20 Hours
Although abdominal X-rays are one of the most frequently used imaging methods in emergencies, they are not as reliable as expected.
The desire to quickly evaluate and know the developments in patients being followed in the surgery clinic and intensive care units prompted us to conduct this study.
It has been designed especially for imaging at bedside in order to learn the result of the procedure or the existence and dimensions of undesirable situations in a short time.
Initially, contrast-enhanced abdominal X ray (CE-AXR) was performed to evaluate only biliary tract anastomoses (cholangiography). Evaluation of images (CE-AXR) obtained by the application of catheters, drains, nasogastric tube, or oral contrast agent (iohexol, 300 mg, 50 cc vial) mixed with saline or water in very different clinical situations with satisfactory results (stenosis, patency, functionality, fistula, obstruction, etc.) was performed. File data of patients who underwent CE-AXR in the retrospective observational study were evaluated.
As a result of examining the data of a total of 131 patients, it was determined that CE-AXR, which was performed after liver, biliary tract, pancreas, esophagus, and stomach operations, provided adequate imaging in 74.8% of the cases and contributed to the diagnosis and treatment process. No complications related to the procedure were observed.
CE-AXR is a very simple imaging method that has no side effects. It can be very useful in clinics and intensive care units because it can be done with mobile X-ray devices at bedside and give fast results. It also has advantages such as reducing the burden of the radiology unit and exposure to radiation.
CE-AXR can contribute to the diagnosis and treatment process in patients with upper gastrointestinal (esophagus and stomach) and hepatopancratobiliary surgeries, chemotherapy patients, and cases with persistent nausea-vomiting complaints and suspected intestinal obstruction. Prospective clinical studies are needed to better understand the effectiveness of CE-AXR.